| Original language | English |
|---|---|
| Journal | BMC Cancer |
| Volume | 19 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2019 |
Cite this
De Giovanni, C., Nanni, P., Landuzzi, L., Ianzano, M. L., Nicoletti, G., Croci, S., ... Lollini, P-L. (2019). Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis. BMC Cancer, 19(1). https://doi.org/10.1186/s12885-019-5339-4
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis. / De Giovanni, C.; Nanni, P.; Landuzzi, L.; Ianzano, M.L.; Nicoletti, G.; Croci, S.; Palladini, A.; Lollini, P.-L.
In: BMC Cancer, Vol. 19, No. 1, 2019.Research output: Contribution to journal › Article
De Giovanni, C, Nanni, P, Landuzzi, L, Ianzano, ML, Nicoletti, G, Croci, S, Palladini, A & Lollini, P-L 2019, 'Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis', BMC Cancer, vol. 19, no. 1. https://doi.org/10.1186/s12885-019-5339-4
De Giovanni C, Nanni P, Landuzzi L, Ianzano ML, Nicoletti G, Croci S et al. Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis. BMC Cancer. 2019;19(1). https://doi.org/10.1186/s12885-019-5339-4
@article{3fd49f9bee184373b6e9acb668614cde,
title = "Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis",
author = "{De Giovanni}, C. and P. Nanni and L. Landuzzi and M.L. Ianzano and G. Nicoletti and S. Croci and A. Palladini and P.-L. Lollini",
note = "Export Date: 12 March 2019",
year = "2019",
doi = "10.1186/s12885-019-5339-4",
language = "English",
volume = "19",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",
number = "1",
}
TY - JOUR
T1 - Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
AU - De Giovanni, C.
AU - Nanni, P.
AU - Landuzzi, L.
AU - Ianzano, M.L.
AU - Nicoletti, G.
AU - Croci, S.
AU - Palladini, A.
AU - Lollini, P.-L.
N1 - Export Date: 12 March 2019
PY - 2019
Y1 - 2019
U2 - 10.1186/s12885-019-5339-4
DO - 10.1186/s12885-019-5339-4
M3 - Article
VL - 19
JO - BMC Cancer
JF - BMC Cancer
SN - 1471-2407
IS - 1
ER -